These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35328542)

  • 1. Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.
    George G; Koyiparambath VP; Sukumaran S; Nair AS; Pappachan LK; Al-Sehemi AG; Kim H; Mathew B
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.
    Thapa P; Upadhyay SP; Suo WZ; Singh V; Gurung P; Lee ES; Sharma R; Sharma M
    Bioorg Chem; 2021 Mar; 108():104681. PubMed ID: 33571811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Multitarget Molecules Incorporating the Enone Moiety.
    Liargkova T; Eleftheriadis N; Dekker F; Voulgari E; Avgoustakis C; Sagnou M; Mavroidi B; Pelecanou M; Hadjipavlou-Litina D
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30621100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY
    Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives.
    Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK
    Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
    Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
    Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFT Study of Regio- and Stereoselective 13DC Reaction between Diazopropane and Substituted Chalcone Derivatives: Molecular Docking of Novel Pyrazole Derivatives as Anti-Alzheimer's Agents.
    Al-Hazmy SM; Zouaghi MO; Amri N; Arfaoui Y; Alhagri IA; Hamdi N
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Privileged Pharmacophore of FDA Approved Drugs in Combination with Chalcone Framework: A New Hope for Alzheimer's Treatment.
    Mathew B
    Comb Chem High Throughput Screen; 2020; 23(9):842-846. PubMed ID: 32723232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
    Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review.
    Mathew B; Parambi DGT; Sivasankarapillai VS; Uddin MS; Suresh J; Mathew GE; Joy M; Marathakam A; Gupta SV
    CNS Neurol Disord Drug Targets; 2019; 18(6):432-445. PubMed ID: 31187716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcone-based carbamates for Alzheimer's disease treatment.
    Rampa A; Montanari S; Pruccoli L; Bartolini M; Falchi F; Feoli A; Cavalli A; Belluti F; Gobbi S; Tarozzi A; Bisi A
    Future Med Chem; 2017 May; 9(8):749-764. PubMed ID: 28498775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Cholinesterase Activity of Chalcone Derivatives: Synthesis, In Vitro Assay and Molecular Docking Study.
    Riswanto FDO; Rawa MSA; Murugaiyah V; Salin NH; Istyastono EP; Hariono M; Wahab HA
    Med Chem; 2021; 17(5):442-452. PubMed ID: 31808389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Discovery Progress of Some Emerging Anti-infective Chalcones: Highlights from 2016 to 2017.
    Mahapatra DK; Ghorai S; Bharti SK; Patil AG; Gayen S
    Curr Drug Discov Technol; 2020; 17(1):30-44. PubMed ID: 30033873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors.
    Polo E; Ibarra-Arellano N; Prent-Peñaloza L; Morales-Bayuelo A; Henao J; Galdámez A; Gutiérrez M
    Bioorg Chem; 2019 Sep; 90():103034. PubMed ID: 31280015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.
    Parambi DGT; Aljoufi F; Murugaiyah V; Mathew GE; Dev S; Lakshminarayanan B; Hendawy OM; Mathew B
    Cent Nerv Syst Agents Med Chem; 2019; 19(1):67-71. PubMed ID: 30451121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
    Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
    Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.